Tavaborole
- Generic Name
- Tavaborole
- Brand Names
- Kerydin
- Drug Type
- Small Molecule
- Chemical Formula
- C7H6BFO2
- CAS Number
- 174671-46-6
- Unique Ingredient Identifier
- K124A4EUQ3
- Background
Tavaborale is a novel, boron-based topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed due to Trichophyton rubrum or Trichophyton mentagrophytes infection. Tavaborole functions by inhibiting Leucyl-tRNA synthetase, or LeuRS, an essential fungal enzyme required for protein synthesis and for the catalysis of ATP-dependent ligation of L-leucine to tRNA(Leu).
- Indication
Indicated for the treatment of onychomycosis (a fungal infection) of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
- Associated Conditions
- Onychomycosis of the Toenails caused by Trichophyton mentagrophytes, Onychomycosis of the Toenails caused by Trichophyton rubrum
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath